BI 113608 Administered as Tablets Twice Daily Over 4 Weeks in Patients With Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis

NCT01958008 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Placebo to BI 113608 high dose b.i.d.
DRUG: Placebo to BI 113608 low dose b.i.d.
DRUG: BI 113608 high dose b.i.d.
DRUG: Placebo to BI 113608 medium dose b.i.d.
DRUG: BI 113608 low dose b.i.d.
DRUG: BI 113608 medium dose b.i.d.

Sponsor

Boehringer Ingelheim